Verapamil causes decreased diaphragm endurance but no decrease of nocturnal O(2) saturation in patients with chronic obstructive pulmonary disease.
Broeders, M E
Verapamil causes decreased diaphragm endurance but no decrease of nocturnal O(2) saturation in patients with chronic obstructive pulmonary disease. [electronic resource] - European journal of clinical pharmacology Jan 2000 - 729-32 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0031-6970
10.1007/s002280050005 doi
Aged
Blood Gas Analysis
Calcium Channel Blockers--pharmacology
Circadian Rhythm--physiology
Cross-Over Studies
Diaphragm--drug effects
Double-Blind Method
Drug Interactions
Humans
Lung Diseases, Obstructive--metabolism
Middle Aged
Muscle Contraction--drug effects
Muscle, Skeletal--drug effects
Oxygen--metabolism
Placebos
Theophylline--pharmacology
Vasodilator Agents--pharmacology
Verapamil--pharmacology
Verapamil causes decreased diaphragm endurance but no decrease of nocturnal O(2) saturation in patients with chronic obstructive pulmonary disease. [electronic resource] - European journal of clinical pharmacology Jan 2000 - 729-32 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0031-6970
10.1007/s002280050005 doi
Aged
Blood Gas Analysis
Calcium Channel Blockers--pharmacology
Circadian Rhythm--physiology
Cross-Over Studies
Diaphragm--drug effects
Double-Blind Method
Drug Interactions
Humans
Lung Diseases, Obstructive--metabolism
Middle Aged
Muscle Contraction--drug effects
Muscle, Skeletal--drug effects
Oxygen--metabolism
Placebos
Theophylline--pharmacology
Vasodilator Agents--pharmacology
Verapamil--pharmacology